First Light Asset Management’s Sutro Biopharma STRO Stock Holding History

First Light Asset Management’s Portfolio STRO Stock Details STRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-167,250	Closed	-$13.7M	–	74
2022 Q1	$13.7M	Sell	167,250 -57,409	-26%	-$5.46M	1.21%	27
2021 Q4	$33.4M	Buy	224,659 +5,515	+3%	+$988K	2.39%	15
2021 Q3	$41.4M	Buy	219,144 +11,856	+6%	+$2.25M	2.73%	12
2021 Q2	$38.5M	Buy	207,288 +1,443	+0.7%	+$282K	2.31%	18
2021 Q1	$46.9M	Buy	205,845 +123,135	+149%	+$29.2M	3.11%	10
2020 Q4	$18M	Buy	+82,710	New	+$13.7M	1.33%	28

Other funds holding STRO

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

First Light Asset Management's STRO Position: Q2 2022 in Review

First Light Asset Management sold out of Sutro Biopharma (STRO) in Q2 2022, closing a stake of 167,250 shares — an estimated $13.7M sold.

First Light Asset Management first reported a position in STRO in Q4 2020 and held it in 6 quarters. The position peaked at $46.9M in Q1 2021. 114 funds tracked by Wall St. Rank hold STRO as of Q2 2022.

First Light Asset Management reported no remaining Sutro Biopharma position as of Q2 2022 after selling out during the quarter.
First Light Asset Management sold 167,250 Sutro Biopharma shares in Q2 2022, an estimated $13.7M.
First Light Asset Management first reported a position in Sutro Biopharma in Q4 2020 and held it in 6 quarters.
First Light Asset Management's Sutro Biopharma position peaked at $46.9M in Q1 2021.
114 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2022.

Based on First Light Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.